• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] MicroRNA‑655 inhibits cell proliferation and invasion in epithelial ovarian cancer by directly targeting vascular endothelial growth factor.[已撤回] 微小RNA-655通过直接靶向血管内皮生长因子抑制上皮性卵巢癌的细胞增殖和侵袭。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12860. Epub 2022 Sep 28.
2
[Retracted] MicroRNA‑874 inhibits proliferation and invasion of pancreatic ductal adenocarcinoma cells by directly targeting paired box 6.[已撤回] 微小RNA‑874通过直接靶向配对盒6抑制胰腺导管腺癌细胞的增殖和侵袭。
Mol Med Rep. 2022 Dec;26(6). doi: 10.3892/mmr.2022.12873. Epub 2022 Oct 20.
3
[Retracted] Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN.[已撤回] 微小RNA-198的下调通过直接靶向PTEN抑制视网膜母细胞瘤细胞的增殖和侵袭。
Mol Med Rep. 2022 Oct;26(4). doi: 10.3892/mmr.2022.12831. Epub 2022 Aug 25.
4
[Retracted] MicroRNA‑379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway.[已撤回] 微小RNA-379通过靶向黏附素并调节PTEN/AKT通路抑制胶质瘤细胞增殖和侵袭。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12853. Epub 2022 Sep 14.
5
[Retracted] MicroRNA‑655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway.[已撤回] 微小RNA‑655通过直接靶向黏附素并调节PTEN/AKT信号通路抑制口腔鳞状细胞癌的细胞增殖和侵袭。
Mol Med Rep. 2023 Jan;27(1). doi: 10.3892/mmr.2022.12897. Epub 2022 Nov 16.
6
[Retracted] MicroRNA‑433 reduces cell proliferation and invasion in non‑small cell lung cancer via directly targeting E2F transcription factor 3.[撤回] 微小RNA-433通过直接靶向E2F转录因子3降低非小细胞肺癌中的细胞增殖和侵袭。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12857. Epub 2022 Sep 21.
7
[Retracted] MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.[已撤回] 微小RNA-497通过直接靶向AKT3抑制甲状腺乳头状癌的细胞增殖、迁移和侵袭。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12843. Epub 2022 Sep 7.
8
[Retracted] microRNA‑574 inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting zinc finger E‑box‑binding homeobox 1.[已撤回] 微小RNA-574通过直接靶向锌指E盒结合同源框1抑制多形性胶质母细胞瘤中的细胞增殖和侵袭。
Mol Med Rep. 2022 Dec;26(6). doi: 10.3892/mmr.2022.12884. Epub 2022 Oct 25.
9
[Retracted] MicroRNA‑760 inhibits cell proliferation and invasion of colorectal cancer by targeting the SP1‑mediated PTEN/AKT signalling pathway.[撤回]微小RNA-760通过靶向SP1介导的PTEN/AKT信号通路抑制结直肠癌的细胞增殖和侵袭。
Mol Med Rep. 2022 Aug;26(2). doi: 10.3892/mmr.2022.12783. Epub 2022 Jun 28.
10
[Retracted] MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin.[已撤回] 微小RNA-874通过直接靶向黏附素抑制视网膜母细胞瘤细胞的增殖和侵袭。
Mol Med Rep. 2023 Jan;27(1). doi: 10.3892/mmr.2022.12900. Epub 2022 Nov 23.

[已撤回] 微小RNA-655通过直接靶向血管内皮生长因子抑制上皮性卵巢癌的细胞增殖和侵袭。

[Retracted] MicroRNA‑655 inhibits cell proliferation and invasion in epithelial ovarian cancer by directly targeting vascular endothelial growth factor.

作者信息

Zhao Ziling, Yang Shuna, Cheng Yan, Zhao Xiuhua

机构信息

Department of Obstetrics and Gynecology, Yidu Central Hospital of Weifang, Weifang, Shandong 262550, P.R. China.

Department of Clinical Laboratory, Jinan Hospital for Infectious Diseases, Jinan, Shandong 250021, P.R. China.

出版信息

Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12860. Epub 2022 Sep 28.

DOI:10.3892/mmr.2022.12860
PMID:36169171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9551397/
Abstract

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the cell invasion assay data shown in Figs. 2C and 4C were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 18: 1878‑1884, 2018; DOI: 10.3892/mmr.2018.9090].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,图2C和4C中所示的某些细胞侵袭试验数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给[期刊名称]之前已在其他地方发表,或已在考虑发表,编辑决定将本文从该期刊撤回。已要求作者对这些问题作出解释,但编辑部未收到答复。编辑就由此造成的不便向读者致歉。[《分子医学报告》18: 1878 - 1884, 2018; DOI: 10.3892/mmr.2018.9090]